Insider trading

Period: 120 months Stock: IRON Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

87 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

87 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

87 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

87 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
87 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
87 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

87 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 Sep 2026
Bitterman Kevin Director
Sold at will
$1.90M 27,136 at 70.11
100%
Sold half or more
17 Feb 2026
Quisel John D Chief Executive Officer
Sold at will
$833.78K 13,264 at 62.86
5.5%
Not planned
17 Feb 2026
Stephenson Pamela Chief Commercial Officer
Sold at will
$347.68K 5,531 at 62.86
6.4%
Not planned
17 Feb 2026
Savage William Jacob Chief Medical Officer
Sold at will
$204.67K 3,256 at 62.86
3.4%
Not planned
17 Feb 2026
Yu Jonathan Yen-Wen Chief Operating Officer
Sold at will
$203.10K 3,231 at 62.86
5.6%
Not planned
17 Feb 2026
Khara Rahul Chief Legal Officer
Sold at will
$179.34K 2,853 at 62.86
5.2%
Not planned
17 Dec 2025
Bitterman Kevin Director · indirect
Sold at will 3×
$68.97K 754 at 91.47
5.1%
Not planned
16 Dec 2025
Bitterman Kevin Director · indirect
Sold at will 3×
$6.29M 68,923 at 91.24
83.0%
Sold half or more
15 Dec 2025
Bitterman Kevin Director · indirect
Sold at will 6×
$5.72M 62,693 at 91.28
68.7%
Sold half or more
15 Dec 2025
Bitterman Kevin Director
Sold at will
$643.09K 7,000 at 91.87
100%
Sold half or more
12 Dec 2025
Bitterman Kevin Director · indirect
Sold at will 9×
$4.20M 45,507 at 92.39
52.3%
Sold half or more
22 Oct 2025
AI DMI LLC 10% owner
Sold at will
$59.87M 744,047 at 80.47
20.9%
Not planned
17 Oct 2025
Bitterman Kevin Director · indirect
Sold at will 14×
$6.22M 70,000 at 88.91
15.4%
Not planned
16 Oct 2025
Bitterman Kevin Director · indirect
Sold at will
$109.88K 1,425 at 77.11
0.3%
Not planned
15 Oct 2025
Bitterman Kevin Director · indirect
Sold at will 2×
$1.71M 22,160 at 77.23
4.4%
Not planned
8 Oct 2025
Bitterman Kevin Director · indirect
Sold at will 5×
$5.08M 71,961 at 70.58
12.6%
Not planned
7 Oct 2025
Bitterman Kevin Director · indirect
Sold at will 2×
$1.23M 18,039 at 68.38
3.1%
Not planned
24 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$797.23K 13,033 at 61.17
2.0%
Not planned
23 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$1.82M 29,837 at 60.97
4.4%
Not planned
18 Jul 2025
Bitterman Kevin Director · indirect
Sold at will
$40.59K 664 at 61.13
0.1%
Not planned
24 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$310.48K 5,738 at 54.11
3.0%
Not planned
24 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$310.48K 5,738 at 54.11
3.0%
Not planned
21 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$540.59K 10,011 at 54.00
5.1%
Not planned
21 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$540.59K 10,011 at 54.00
5.1%
Not planned
20 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$149.18K 2,762 at 54.01
1.4%
Not planned
20 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$149.18K 2,762 at 54.01
1.4%
Not planned
19 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$2.14M 39,656 at 54.02
17.3%
Not planned
19 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$2.14M 39,656 at 54.02
17.3%
Not planned
12 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 6×
$4.53M 83,182 at 54.45
30.0%
Not planned
12 Mar 2025
Ashiya Mona Director · indirect
Sold at will 6×
$4.53M 83,182 at 54.45
30.0%
Not planned
11 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 3×
$1.46M 27,056 at 54.01
11.7%
Not planned
11 Mar 2025
Ashiya Mona Director · indirect
Sold at will 3×
$1.46M 27,056 at 54.01
11.7%
Not planned
10 Mar 2025
Ashiya Mona Director · indirect
Sold at will 6×
$10.97M 202,146 at 54.29
49.2%
Not planned
10 Mar 2025
ORBIMED ADVISORS LLC Director · indirect
Sold at will 6×
$10.97M 202,146 at 54.29
49.2%
Not planned
18 Feb 2025
Quisel John D Chief Executive Officer
Sold at will
$304.23K 5,574 at 54.58
3.5%
Not planned
18 Feb 2025
Stephenson Pamela Chief Commercial Officer
Sold at will
$171.22K 3,137 at 54.58
4.3%
Not planned
18 Feb 2025
Franchi Jean M. Chief Financial Officer
Sold at will
$171.16K 3,136 at 54.58
4.3%
Not planned
18 Feb 2025
Savage William Jacob Chief Medical Officer
Sold at will
$89.40K 1,638 at 54.58
2.3%
Not planned
18 Feb 2025
Yu Jonathan Yen-Wen Chief Operating Officer
Sold at will
$87.87K 1,610 at 54.58
3.8%
Not planned
18 Feb 2025
Khara Rahul Chief Legal Officer
Sold at will
$63.37K 1,161 at 54.58
3.0%
Not planned
17 Jun 2024
Bitterman Kevin Director · indirect
Bought
$8.00M 222,223 at 36.00
112%
First buy on file
17 Jun 2024
Ashiya Mona Director · indirect
Bought 3×
$3.00M 83,334 at 36.00
9.7%
Largest buy in 3 yrs
17 Jun 2024
ORBIMED ADVISORS LLC Director · indirect
Bought 3×
$3.00M 83,334 at 36.00
9.7%
Largest buy in 3 yrs
5 Mar 2024
Bitterman Kevin Director · indirect
Sold at will
$1.92M 26,157 at 73.50
3.7%
Not planned
23 Jan 2024
Bitterman Kevin Director · indirect
Sold at will 2×
$6.93M 102,500 at 67.65
34.1%
Not planned
23 Jan 2024
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will 2×
$6.93M 102,500 at 67.65
34.1%
Not planned
23 Jan 2024
Sold at will
$3.21M 47,500 at 67.65
3.3%
Not planned
10 Jan 2024
Sold at will
$1.92M 30,000 at 64.00
2.0%
Not planned
10 Jan 2024
Atlas Venture Fund X, L.P. 10% owner · indirect
Sold at will
$1.28M 20,000 at 64.00
2.5%
Not planned
10 Jan 2024
Bitterman Kevin Director · indirect
Sold at will
$1.28M 20,000 at 64.00
2.5%
Not planned
Showing 1–50 of 87. Page 1 of 2 Older →